{"id":"NCT00308139","sponsor":"AstraZeneca","briefTitle":"Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)","officialTitle":"A Randomized, Open-Label, Multicenter, Comparator-Controlled Study to Examine the Effects of Exenatide Long-Acting Release on Glucose Control (HbA1c) and Safety in Subjects With Type 2 Diabetes Mellitus Managed With Diet Modification and Exercise and/or Oral Antidiabetic Medications","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-04","primaryCompletion":"2008-07","completion":"2014-08","firstPosted":"2006-03-29","resultsPosted":"2012-08-17","lastUpdate":"2015-08-26"},"enrollment":303,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"exenatide, long acting release","otherNames":["BYDUREON"]},{"type":"DRUG","name":"exenatide","otherNames":["Byetta"]}],"arms":[{"label":"Exenatide Once Weekly","type":"EXPERIMENTAL"},{"label":"Exenatide Twice Daily","type":"ACTIVE_COMPARATOR"}],"summary":"A Randomized, Open-Label, Multicenter, Comparator-Controlled Study to Examine the Effects of Exenatide Long-Acting Release (LAR) on Glucose Control (HbA1c) and Safety in Subjects with Type 2 Diabetes Mellitus Managed with Diet Modification and Exercise and/or Oral Antidiabetic Medications.","primaryOutcome":{"measure":"Change in HbA1c From Baseline to Week 30","timeFrame":"Day -3, Week 30","effectByArm":[{"arm":"Exenatide Once Weekly","deltaMin":-1.87,"sd":0.082},{"arm":"Exenatide Twice Daily","deltaMin":-1.54,"sd":0.082}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0023"}]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":25,"countries":["United States","Canada"]},"refs":{"pmids":["30600137","27525540","25744115","23748506","23358123","23166441","22236356","21529363","20215461","18782641"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":148},"commonTop":["Upper respiratory tract infection","Nausea","Diarrhoea","Nasopharyngitis","Sinusitis"]}}